GRACEcast Cancer 101 Audio

Dr. Ramalingam answers questions on the changing landscape of cancer clinical trials and how new studies are being designed in the new era of molecular oncology.

Dr. Ramalingam, from Winship Cancer Center at Emory University in Atlanta, dispels several myths that have created barriers to patient participation in clinical trials and highlights the rights of a patient interested in enrolling on a study.

Dr. Ramalingam, from Winship Cancer Center at Emory University in Atlanta, explains the process of developing a clinical trial, from identifying the most important questions to navigating it through the design and implementation process and enrolling patients.

Dr. Ramalingam, from Winship Cancer Center at Emory University in Atlanta, reviews what constitutes a clinical trial and discusses the phases of studies in the process of clinical research.

Dr. Dara Aisner, Pathologist at the University of Colorado, describes emerging technological changes that will advance how molecular marker testing is done, to make it faster and more complete over time.

Dr. Dara Aisner, Pathologist at the University of Colorado, reviews several practical challenges about having enough tissue for molecular testing, as well as the accuracy of the tests in different labs.

Dr. Dara Aisner, Pathologist at the University of Colorado, defines the field of pathology and molecular marker testing for cancer.

The GRACEcast feeds on iTunes are moving!

Dr. Kristin Manning, expert radiologist at Seattle Radiology, discusses difficulties in characterizing ambiguous imaging findings and the potential risks associated with radiation from medical imaging.

This interview by medical oncologist Dr. Jack West of Dr. David Djang, nuclear medicine expert in Seattle, covers the general principles and clinical utility of PET scans in lung cancer and other aspects of oncology.